United States · FDA National Drug Code directory
everolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82293-030_4ca7b927-0d89-0be6-e063-6394a90af200
- Product NDC
- 82293-030
- Form
- TABLET
- Composition / generic term
- everolimus
- Labeler
- Novugen Pharma (USA) LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260330
- Source listing expiry
- 20271231
Source-listed ingredients
- EVEROLIMUS — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 TABLET in 1 BOTTLE (82293-030-10) · 82293-030-10
- 4 BLISTER PACK in 1 CARTON (82293-030-21) / 7 TABLET in 1 BLISTER PACK (82293-030-20) · 82293-030-21
- 1 POUCH in 1 CARTON (82293-030-31) / 3 BLISTER PACK in 1 POUCH / 10 TABLET in 1 BLISTER PACK (82293-030-30) · 82293-030-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →